SCHEMBL796755

SCHEMBL796755

CCc1c2c(c(CC)c(C(=O)OC)c1C(=O)OC)Cc1c(c(CC)c3cc4c(CC)c(CC)c(CC)c(CC)c4cc3c1CC)C2

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 3/20 0.33
ALDH1A1 P00352 3/20 0.33
HCRTR1 O43613 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA7 P43166 1/20 0.33
CA9 Q16790 1/20 0.33
CA14 Q9ULX7 1/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
CYP3A4 P08684 3/20 0.33
ACHE P22303 1/20 0.33
KDM4E B2RXH2 3/20 0.32
HSD17B10 Q99714 3/20 0.32
HPGD P15428 3/20 0.32
MAPT P10636 2/20 0.32
LMNA P02545 2/20 0.32
TSHR P16473 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13815353 0.90 MEN1 (0.37) CNR2ALDH1A1HCRTR1RXFP1MEN1
SCHEMBL10079139 0.88 MEN1 (0.38) CNR2ALDH1A1HCRTR1RXFP1MEN1
SCHEMBL10079127 0.87 CA12 (0.39) CNR2ALDH1A1HCRTR1RXFP1CA12
SCHEMBL797846 0.87 LMNA (0.37) CNR2ALDH1A1HCRTR1RXFP1CA12
SCHEMBL10079123 0.86 PTPN1 (0.34) CNR2ALDH1A1HCRTR1RXFP1MEN1
SCHEMBL797431 0.85 CA12 (0.38) CNR2ALDH1A1HCRTR1RXFP1CA12
SCHEMBL796843 0.82 LDHA (0.40) ALDH1A1RXFP1MEN1KMT2AHSD17B10
SCHEMBL10079131 0.81 MEN1 (0.43) CNR2ALDH1A1HCRTR1RXFP1CA12
SCHEMBL13815350 0.79 MEN1 (0.42) CNR2ALDH1A1HCRTR1RXFP1CA12
SCHEMBL10079130 0.79 MEN1 (0.42) CNR2ALDH1A1HCRTR1RXFP1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8115197-B2 Organic semiconductor material, organic semiconductor thin film and organic semiconductor device SONY CORPORATION (JP) 2012-02-14 US disclosed
EP-1262469-B1 POLYACENE DERIVATIVES AND PRODUCTION THEREOF JAPAN SCIENCE & TECH AGENCY (JP) 2012-01-11 EP disclosed
US-7901594-B2 Electroconductivity JAPAN SCIENCE AND TECHNOLOGY CORPORATION (JP) 2011-03-08 US disclosed
US-20090230387-A1 ORGANIC SEMICONDUCTOR MATERIAL, ORGANIC SEMICONDUCTOR THIN FILM AND ORGANIC SEMICONDUCTOR DEVICE SONY CORPORATION (JP) 2009-09-17 US disclosed
US-20090140241-A1 ORGANIC SEMICONDUCTOR MATERIAL, ORGANIC SEMICONDUCTOR THIN FILM AND ORGANIC SEMICONDUCTOR DEVICE SONY CORPORATION (JP) 2009-06-04 US disclosed
US-20030116755-A1 Polyacene derivatives and production thereof JAPAN SCIENCE AND TECHNOLOGY CORPORATION (JP) 2003-06-26 US disclosed
EP-1262469-A1 POLYACENE DERIVATIVES AND PRODUCTION THEREOF Japan Science and Technology Corporation (JP) 2002-12-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090140241-A1 ORGANIC SEMICONDUCTOR MATERIAL, ORGANIC SEMICONDUCTOR THIN FILM AND ORGANIC SEMICONDUCTOR DEVICE H1-10, OR10J3, H1-0 CNR2 3388/4885ALDH1A1 2407/4885HCRTR1 429/4885
US-20090230387-A1 ORGANIC SEMICONDUCTOR MATERIAL, ORGANIC SEMICONDUCTOR THIN FILM AND ORGANIC SEMICONDUCTOR DEVICE H1-10, OR10J3, H1-0 CNR2 3388/4885ALDH1A1 2407/4885HCRTR1 429/4885
US-20030116755-A1 Polyacene derivatives and production thereof CBR1, HVCN1, H1-0 CNR2 1020/4885ALDH1A1 591/4885HCRTR1 655/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.